Recent studies carried out on an adult population with CD have demonstrated that PNPLA3 I148M gene variant is associated with the development and severity of hepatic steatosis, but not related to metabolic disorders [129,133]. The gene discussed is PNPLA3; the disease is fatty liver disease.